ArticleOncoimmunology2024
Targeting the activin receptor 1C on CD4+ T cells for cancer immunotherapy.
Ying Zheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleOncoimmunology2024
Ying Zheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.